0001017491-16-000178.txt : 20160520 0001017491-16-000178.hdr.sgml : 20160520 20160520181840 ACCESSION NUMBER: 0001017491-16-000178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160520 FILED AS OF DATE: 20160520 DATE AS OF CHANGE: 20160520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APRICUS BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001017491 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870449967 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STREET 2: SUITE 300 CITY: SAN DIEGO, STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 222-8041 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STREET 2: SUITE 300 CITY: SAN DIEGO, STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: NEXMED INC DATE OF NAME CHANGE: 19970311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dorsey Brian CENTRAL INDEX KEY: 0001380762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22245 FILM NUMBER: 161667495 MAIL ADDRESS: STREET 1: C/O SOMAXON PHARMACEUTICALS, INC. STREET 2: 10935 VISTA SORRENTO PARKWAY, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 wf-form4_146378270696341.xml FORM 4 X0306 4 2016-05-20 0 0001017491 APRICUS BIOSCIENCES, INC. APRI 0001380762 Dorsey Brian 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 0 1 0 0 SVP, Chief Development Officer Common Stock 2016-05-20 4 A 0 250000 A 301891 D Award of 250,000 Restricted Stock Units ("RSUs") under the Issuer's 2012 Stock Long Term Incentive Plan with half of the underlying shares vesting on the Company's receipt of marketing approval of Vitaros in the United States by the Food and Drug Administration on or before December 31, 2018 and the other half of the underlying shares vesting on January 1, 2018, subject to the Reporting Person's continued employment or service to the Issuer through such date. Not applicable. /s/ Richard W. Pascoe by power of attorney for Brian Dorsey 2016-05-20